{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T07:35:19Z","timestamp":1771054519092,"version":"3.50.1"},"reference-count":101,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[1996,12,1]],"date-time":"1996-12-01T00:00:00Z","timestamp":849398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1996,12,1]],"date-time":"1996-12-01T00:00:00Z","timestamp":849398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2004,6,21]],"date-time":"2004-06-21T00:00:00Z","timestamp":1087776000000},"content-version":"vor","delay-in-days":2759,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[1996,12]]},"DOI":"10.1016\/s0190-9622(96)90122-x","type":"journal-article","created":{"date-parts":[[2004,6,23]],"date-time":"2004-06-23T10:58:17Z","timestamp":1087988297000},"page":"969-979","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":298,"title":["Rediscovering thalidomide: A review of its mechanism of action, side effects, and potential uses"],"prefix":"10.1016","volume":"35","author":[{"given":"Stephanie","family":"Tseng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grace","family":"Pak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth","family":"Washenik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam","family":"Keltz Pomeranz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerome L","family":"Shupack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S0190-9622(96)90122-X_BIB1","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1056\/NEJM196212062672305","article-title":"The saga of thalidomide: neuropathy to embryopathy, with case reports and congenital abnormalities","volume":"23","author":"Mellin","year":"1962","journal-title":"N Engl J Med"},{"key":"10.1016\/S0190-9622(96)90122-X_BIB2","first-page":"65","article-title":"Thalidomide revisited","volume":"13","author":"D'Arcy","year":"1994","journal-title":"Adverse Drug React Toxicol Rev"},{"key":"10.1016\/S0190-9622(96)90122-X_BIB3","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0079-6468(08)70231-5","article-title":"Thalidomide and congeners as anti-inflammatory agents","volume":"22","author":"Koch","year":"1985","journal-title":"Prog Med Chem"},{"key":"10.1016\/S0190-9622(96)90122-X_BIB4","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1056\/NEJM196212132672407","article-title":"The saga of thalidomide (concluded)","volume":"24","author":"Mellin","year":"1962","journal-title":"N Engl J Med"},{"key":"10.1016\/S0190-9622(96)90122-X_BIB5","doi-asserted-by":"crossref","first-page":"116","DOI":"10.2165\/00002018-199207020-00004","article-title":"Thalidomide in human immunodeficiency virus (HIV) patients: a review of safety considerations","volume":"7","author":"Gunzler","year":"1992","journal-title":"Drug Saf"},{"key":"10.1016\/S0190-9622(96)90122-X_BIB6","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/0306-9877(83)90009-9","article-title":"Thalidomide for autoimmune disease","volume":"10","author":"Hendler","year":"1983","journal-title":"Med Hypotheses"},{"key":"10.1016\/S0190-9622(96)90122-X_BIB7","first-page":"111","article-title":"Pharmacological properties of thalidomide (\u03b1-phthalimido glutarimide), a new sedative hypnotic drug","volume":"15","author":"Somers","year":"1960","journal-title":"Br J Pharmacol"},{"key":"10.1016\/S0190-9622(96)90122-X_BIB8","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/chir.530070109","article-title":"Sterospecific determination, chiral inversion in vitro and pharmacokinetics in humans of the enantiomers of thalidomide","volume":"7","author":"Eriksson","year":"1995","journal-title":"Chirality"},{"key":"10.1016\/S0190-9622(96)90122-X_BIB9","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S0090-9556(25)07646-9","article-title":"Plasma pharmacokinetics and urinary excretion of thalidomide after oral dosing in healthy male volunteers","volume":"17","author":"Chen","year":"1989","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/S0190-9622(96)90122-X_BIB10","first-page":"338","article-title":"The metabolism of thalidomide: the fate of thalidomide and some of its hydrolysis products in various species","volume":"25","author":"Schumacher","year":"1965","journal-title":"Br J Pharmacol"},{"key":"10.1016\/S0190-9622(96)90122-X_BIB11","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0041-008X(86)90449-7","article-title":"Teratogen metabolism: thalidomide activation is mediated by cytochrome P-450","volume":"82","author":"Braun","year":"1986","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/S0190-9622(96)90122-X_BIB12","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1136\/bmj.2.5463.687","article-title":"Prolongation of skin homograft survival by thalidomide","volume":"2","author":"Hellman","year":"1965","journal-title":"Br Med J"},{"key":"10.1016\/S0190-9622(96)90122-X_BIB13","first-page":"271","article-title":"Erythropoietin release in renal allografted baboons, with and without immunosuppression","volume":"7","author":"Murphy","year":"1970","journal-title":"Invest Urol"},{"key":"10.1016\/S0190-9622(96)90122-X_BIB14","first-page":"133","article-title":"Autoimmune diseases and thalidomide: I. adjuvant disease, experimental allergic encephalomyelitis and experimental allergic neuritis of the guinea pig","volume":"40","author":"Goihman-Yahr","year":"1972","journal-title":"Int J Lepr"},{"key":"10.1016\/S0190-9622(96)90122-X_BIB15","first-page":"266","article-title":"Autoimmune diseases and thalidomide: II. adjuvant disease, experimental allergic encephalomyelitis and experimental allergic neuritis of the rat","volume":"42","author":"Goihman-Yahr","year":"1974","journal-title":"Int J Lepr"},{"key":"10.1016\/S0190-9622(96)90122-X_BIB16","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/BF00406421","article-title":"Inhibition of PMN leukocytes chemotaxis by thalidomide","volume":"269","author":"Faure","year":"1980","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/S0190-9622(96)90122-X_BIB17","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/S0190-9622(84)80458-2","article-title":"Studies on the anti-inflammatory properties of thalidomide: effects on polymorphonuclear leukocytes and monocytes","volume":"11","author":"Barnhill","year":"1984","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/S0190-9622(96)90122-X_BIB18","first-page":"35","article-title":"Thalidomide induces imbalances in T-lymphocyte sub-populations in the circulating blood of healthy males","volume":"56","author":"Gad","year":"1985","journal-title":"Lepr Rev"},{"key":"10.1016\/S0190-9622(96)90122-X_BIB19","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1084\/jem.173.3.699","article-title":"Thalidomide selectively inhibits tumor necrosis factor \u03b1 production by stimulated human monocytes","volume":"173","author":"Sampaio","year":"1991","journal-title":"J Exp Med"},{"key":"10.1016\/S0190-9622(96)90122-X_BIB20","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1084\/jem.177.6.1675","article-title":"Thalidomide exerts its inhibitory action on tumor necrosis factor \u03b1 by enhancing mRNA degradation","volume":"177","author":"Moreira","year":"1993","journal-title":"J Exp Med"},{"key":"10.1016\/S0190-9622(96)90122-X_BIB21","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1365-2249.1995.tb05527.x","article-title":"The immunosuppressive drug thalidomide induces T helper cell type 2 (Th2) and concomitantly inhibits Th1 cytokine production in mitogen- and antigen-stimulated human peripheral blood mononuclear cell cultures","volume":"99","author":"McHugh","year":"1995","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/S0190-9622(96)90122-X_BIB22","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/j.1365-3083.1981.tb00169.x","article-title":"Inhibition of de novo IgM antibody synthesis by thalidomide as a relevant mechanism of action in leprosy","volume":"13","author":"Shannon","year":"1981","journal-title":"Scand J Immunol"},{"key":"10.1016\/S0190-9622(96)90122-X_BIB23","first-page":"5974","article-title":"Thalidomide inhibits the replication of human immunodeficiency virus type 1","volume":"90","author":"Makonkawkeyoon","year":"1993"},{"key":"10.1016\/S0190-9622(96)90122-X_BIB24","first-page":"4082","article-title":"Thalidomide is an inhibitor of angiogenesis","volume":"91","author":"D'Amato","year":"1994"},{"key":"10.1016\/S0190-9622(96)90122-X_BIB25","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/BF00307645","article-title":"Inhibitory effects of thalidomide on cellular proliferation, endoneurial edema and myelin phagocytosis during early Wallerian degeneration","volume":"89","author":"Schroder","year":"1995","journal-title":"Acta Neuropathol"},{"key":"10.1016\/S0190-9622(96)90122-X_BIB26","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.1365-4362.1980.tb00342.x","article-title":"The treatment of lepra reaction in lepromatous leprosy: fifteen years' experience with thalidomide","volume":"19","author":"Sheskin","year":"1980","journal-title":"Int J Dermatol"},{"key":"10.1016\/S0190-9622(96)90122-X_BIB27","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/infdis\/168.2.408","article-title":"The influence of thalidomide on the clinical and immunologic manifestation of erythema nodosum leprosum","volume":"168","author":"Sampaio","year":"1993","journal-title":"J Infect Dis"},{"key":"10.1016\/S0190-9622(96)90122-X_BIB28","first-page":"5","article-title":"Thalidomide's effectiveness in erythema nodosum leprosum is associated with a decrease in CD4+ cells in the peripheral blood","volume":"63","author":"Shannon","year":"1992","journal-title":"Lepr Rev"},{"key":"10.1016\/S0190-9622(96)90122-X_BIB29","first-page":"215","article-title":"Zur therapie der prurigo nodularis hyde mit thalidomid","volume":"26","author":"Sheskin","year":"1975","journal-title":"Hautarzt"},{"key":"10.1016\/S0190-9622(96)90122-X_BIB30","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1001\/archderm.1980.01640290081018","article-title":"Treatment of prurigo nodularis with thalidomide","volume":"116","author":"Van den Broek","year":"1980","journal-title":"Arch Dermatol"},{"key":"10.1016\/S0190-9622(96)90122-X_BIB31","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1111\/j.1365-4362.1984.tb05696.x","article-title":"Thalidomide therapy for inflammatory dermatoses","volume":"23","author":"Grosshans","year":"1984","journal-title":"Int J Dermatol"},{"key":"10.1016\/S0190-9622(96)90122-X_BIB32","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1365-4362.1973.tb00066.x","article-title":"Thalidomide in the treatment of actinic prurigo","volume":"12","author":"Londono","year":"1973","journal-title":"Int J Dermatol"},{"key":"10.1016\/S0190-9622(96)90122-X_BIB33","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1440-0960.1976.tb00577.x","article-title":"Polymorphous light eruption: treatment with thalidomide","volume":"17","author":"Saul","year":"1976","journal-title":"Australas J Dermatol"},{"key":"10.1016\/S0190-9622(96)90122-X_BIB34","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1365-2230.1977.tb01577.x","article-title":"Actinic prurigo (Hutchinson's summer prurigo)","volume":"32","author":"Calnan","year":"1977","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/S0190-9622(96)90122-X_BIB35","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1365-2133.1983.tb04601.x","article-title":"Thalidomide in actinic prurigo","volume":"108","author":"Lovell","year":"1983","journal-title":"Br J Dermatol"},{"key":"10.1016\/S0190-9622(96)90122-X_BIB36","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/j.1365-4362.1992.tb02732.x","article-title":"Cellular immune effects of thalidomide in actinic prurigo [letter]","volume":"31","author":"Bernal","year":"1992","journal-title":"Int J Dermatol"},{"key":"10.1016\/S0190-9622(96)90122-X_BIB37","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.1365-4362.1989.tb04599.x","article-title":"Treatment of discoid lupus erythematosus","volume":"28","author":"Lo","year":"1989","journal-title":"Int J Dermatol"},{"key":"10.1016\/S0190-9622(96)90122-X_BIB38","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1365-2133.1983.tb04600.x","article-title":"Thalidomide in the treatment of sixty cases of chronic discoid lupus erythematosus","volume":"108","author":"Knop","year":"1983","journal-title":"Br J Dermatol"},{"key":"10.1016\/S0190-9622(96)90122-X_BIB39","first-page":"487","article-title":"Treatment of the cutaneous lesions of systemic lupus erythematosus with thalidomide","volume":"11","author":"Atra","year":"1993","journal-title":"Clin Exp Rheum"},{"key":"10.1016\/S0190-9622(96)90122-X_BIB40","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/0140-6736(92)90365-A","article-title":"Thalidomide for systemic lupus erythematosus","volume":"339","author":"Bessis","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/S0190-9622(96)90122-X_BIB41","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1001\/archderm.1979.04010050060027","article-title":"Thalidomide in the treatment of recurrent, necrotic, and giant mucocutaneous aphthae and aphthosis [letter]","volume":"115","author":"Mascaro","year":"1979","journal-title":"Arch Dermatol"},{"key":"10.1016\/S0190-9622(96)90122-X_BIB42","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0190-9622(85)70014-X","article-title":"Significant response of oral aphthosis to thalidomide treatment","volume":"12","author":"Grinspan","year":"1985","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/S0190-9622(96)90122-X_BIB43","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/S0140-6736(84)91622-2","article-title":"Thalidomide in severe orogenital ulceration","volume":"2","author":"Jenkins","year":"1984","journal-title":"Lancet"},{"key":"10.1016\/S0190-9622(96)90122-X_BIB44","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1365-2133.1985.tb15281.x","article-title":"Thalidomide in the treatment of recurrent necrotic mucocutaneous aphthae (letter)","volume":"112","author":"Kurkcuoglu","year":"1985","journal-title":"Br J Dermatol"},{"key":"10.1016\/S0190-9622(96)90122-X_BIB45","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1177\/000348949510400409","article-title":"Sutton's disease (periadenitis mucosa necrotica recurrents)","volume":"104","author":"Laccourreye","year":"1995","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/S0190-9622(96)90122-X_BIB46","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1001\/archderm.1990.01670310085012","article-title":"Crossover study of thalidomide vs placebo in severe recurrent aphthous stomatitis","volume":"126","author":"Revuz","year":"1990","journal-title":"Arch Dermatol"},{"key":"10.1016\/S0190-9622(96)90122-X_BIB47","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1136\/bmj.298.6671.432","article-title":"Treatment of resistant aphthous ulceration with thalidomide in patients positive for HIV antibody","volume":"298","author":"Youle","year":"1989","journal-title":"Br Med J"},{"key":"10.1016\/S0190-9622(96)90122-X_BIB48","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/0140-6736(90)91223-W","article-title":"Thalidomide in hyperalgic pharyngeal ulceration of AIDS [letter]","volume":"335","author":"Gorin","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/S0190-9622(96)90122-X_BIB49","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0190-9622(08)81115-2","article-title":"Recurrent aphthous ulcer in patient infected with human immunodeficiency virus: successful treatment with thalidomide","volume":"23","author":"Radeff","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/S0190-9622(96)90122-X_BIB50","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1056\/NEJM199207163270319","article-title":"Thalidomide to treat esophageal ulcer in AIDS [letter]","volume":"327","author":"Ryan","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/S0190-9622(96)90122-X_BIB51","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0190-9622(08)81153-X","article-title":"Thalidomide: treatment of choice of aphthous ulcers in patients seropositive for human immunodeficiency virus","volume":"28","author":"Ghigliotti","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/S0190-9622(96)90122-X_BIB52","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1007\/BF02064213","article-title":"Use of thalidomide in treatment and maintenance of idiopathic esophageal ulcers in HIV+ individuals","volume":"40","author":"Naum","year":"1995","journal-title":"Dig Dis Sci"},{"key":"10.1016\/S0190-9622(96)90122-X_BIB53","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1093\/clinids\/20.2.250","article-title":"Thalidomide as treatment of refractory aphthous ulceration related to human immunodeficiency virus infection","volume":"20","author":"Paterson","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.1016\/S0190-9622(96)90122-X_BIB54","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1001\/archderm.1982.01650200004003","article-title":"Thalidomide in the treatment of Behcet's syndrome [letter]","volume":"118","author":"Saylan","year":"1982","journal-title":"Arch Dermatol"},{"key":"10.1016\/S0190-9622(96)90122-X_BIB55","first-page":"427","article-title":"Behcet's disease, palmoplantar pustulosis and HLA-B27: treatment with thalidomide [letter]","volume":"8","author":"Hamza","year":"1990","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/S0190-9622(96)90122-X_BIB56","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1365-2796.1990.tb00253.x","article-title":"Treatment of severe colitis in Beh\u00e7et's syndrome with thalidomide (CG-217)","volume":"228","author":"Larsson","year":"1990","journal-title":"J Int Med"},{"key":"10.1016\/S0190-9622(96)90122-X_BIB57","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1001\/archinte.1986.00360170074012","article-title":"Thalidomide effects in Beh\u00e7et's syndrome and pustular vasculitis","volume":"146","author":"Jorizzo","year":"1986","journal-title":"Arch Intern Med"},{"key":"10.1016\/S0190-9622(96)90122-X_BIB58","first-page":"393","article-title":"Thalidomide for treatment of graft-versus-host disease","volume":"3","author":"Vogelsang","year":"1988","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/S0190-9622(96)90122-X_BIB59","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(88)90312-1","article-title":"Successful treatment with thalidomide of acute graft-versus-host disease after bone-marrow transplantation [letter]","volume":"1","author":"Lim","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/S0190-9622(96)90122-X_BIB60","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0140-6736(88)91151-8","article-title":"Thalidomide for graft-versus-host disease after bone marrow transplantation [letter]","volume":"1","author":"Saurat","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/S0190-9622(96)90122-X_BIB61","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/S0140-6736(88)90546-6","article-title":"Thalidomide for graft-versus-host disease [letter]","volume":"2","author":"McCarthy","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/S0190-9622(96)90122-X_BIB62","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1365-2141.1991.tb04377.x","article-title":"Thalidomide treatment for chronic graft-versus-host disease","volume":"78","author":"Heney","year":"1991","journal-title":"Br J Haematol"},{"key":"10.1016\/S0190-9622(96)90122-X_BIB63","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1056\/NEJM199204163261604","article-title":"Thalidomide for the treatment of chronic graft-versus-host disease","volume":"326","author":"Vogelsang","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/S0190-9622(96)90122-X_BIB64","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/0145-2126(90)90024-4","article-title":"The potential use of thalidomide in the therapy of graft-versus-host disease: a review of clinical and laboratory information","volume":"14","author":"Wood","year":"1990","journal-title":"Leuk Res"},{"key":"10.1016\/S0190-9622(96)90122-X_BIB65","first-page":"963","article-title":"Sarcoides cutanees: Traitement par la thalidomide [letter]","volume":"12","author":"Barriere","year":"1983","journal-title":"Presse Med"},{"key":"10.1016\/S0190-9622(96)90122-X_BIB66","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/0190-9622(95)91549-4","article-title":"Treatment of cutaneous and pulmonary sarcoidosis with thalidomide","volume":"32","author":"Carlesimo","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/S0190-9622(96)90122-X_BIB67","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1002\/art.1780271006","article-title":"Thalidomide: a promising new treatment for rheumatoid arthritis","volume":"27","author":"Gutierrez-Rodriguez","year":"1984","journal-title":"Arthritis Rheum"},{"key":"10.1016\/S0190-9622(96)90122-X_BIB68","first-page":"1387","article-title":"Histiocytose X avec \u2018granulome eosinophile vulvaire\u2019: effect spectaculaire de la thalidomide","volume":"114","author":"Gnassia","year":"1987","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/S0190-9622(96)90122-X_BIB69","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1365-2230.1988.tb01970.x","article-title":"Pure cutaneous histiocytosis resembling sinus histiocytosis","volume":"13","author":"Viraben","year":"1988","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/S0190-9622(96)90122-X_BIB70","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1001\/archderm.1993.01680310031004","article-title":"Successful treatment of adult's Langerhans cell histiocytosis with thalidomide","volume":"129","author":"Thomas","year":"1993","journal-title":"Arch Dermatol"},{"key":"10.1016\/S0190-9622(96)90122-X_BIB71","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1365-2230.1993.tb02262.x","article-title":"Remission of Langerhans cell histiocytosis with thalidomide treatment [letter]","volume":"18","author":"Misery","year":"1993","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/S0190-9622(96)90122-X_BIB72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2133.1995.tb08659.x","article-title":"Adult cutaneous Langerhans cell histiocytosis: remission with thalidomide treatment [letter]","volume":"132","author":"Meunier","year":"1995","journal-title":"Br J Dermatol"},{"key":"10.1016\/S0190-9622(96)90122-X_BIB73","first-page":"67","article-title":"Pyoderma gangrenosum chez un enfant: traitement par la thalidomide","volume":"29","author":"Venencie","year":"1982","journal-title":"Ann Pediatr"},{"key":"10.1016\/S0190-9622(96)90122-X_BIB74","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/S0190-9622(08)80705-0","article-title":"Pyoderma gangrenosum associated with Beh\u00e7et's disease: treatment with thalidomide","volume":"23","author":"Rustin","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/S0190-9622(96)90122-X_BIB75","first-page":"408","article-title":"Pyoderma gangrenosum associated with Beh\u00e7et's syndrome: response to thalidomide","volume":"13","author":"Munro","year":"1988","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/S0190-9622(96)90122-X_BIB76","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1159\/000187978","article-title":"Thalidomide for the treatment of uremic pruritus: a crossover randomized double-blind trial","volume":"67","author":"Silva","year":"1994","journal-title":"Nephron"},{"key":"10.1016\/S0190-9622(96)90122-X_BIB77","first-page":"611","article-title":"Traitement de la maladie de Jessner et Kanof par la thalidomide","volume":"110","author":"Moulin","year":"1983","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/S0190-9622(96)90122-X_BIB78","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2340\/0001555562449450","article-title":"Thalidomide treatment of recurrent erythema multiforme","volume":"62","author":"Bahmer","year":"1982","journal-title":"Acta Derm Venereol (Stockh)"},{"key":"10.1016\/S0190-9622(96)90122-X_BIB79","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1365-2133.1992.tb08415.x","article-title":"Thalidomide for recurrent erythema multiforme [letter]","volume":"126","author":"Moisson","year":"1992","journal-title":"Br J Dermatol"},{"key":"10.1016\/S0190-9622(96)90122-X_BIB80","first-page":"322","article-title":"Cold haemagglutination disease treated by thalidomide","volume":"15","author":"Lewis","year":"1968","journal-title":"Br Soc Haematol"},{"key":"10.1016\/S0190-9622(96)90122-X_BIB81","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0140-6736(77)91039-X","article-title":"Thalidomide in Weber-Christian disease [letter]","volume":"1","author":"Eravelly","year":"1977","journal-title":"Lancet"},{"key":"10.1016\/S0190-9622(96)90122-X_BIB82","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1136\/bmj.1.6166.792","article-title":"Treatment of ulcerative colitis with thalidomide","volume":"1","author":"Waters","year":"1979","journal-title":"Br Med J"},{"key":"10.1016\/S0190-9622(96)90122-X_BIB83","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0190-9622(82)70118-5","article-title":"Thalidomide: use and possible mode of action in reactional lepromatous leprosy and in various other conditions","volume":"7","author":"Barnhill","year":"1982","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/S0190-9622(96)90122-X_BIB84","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1093\/infdis\/166.4.939","article-title":"Thalidomide in painful AIDS-associated proctitis [letter]","volume":"166","author":"Wallach","year":"1992","journal-title":"J Infect Dis"},{"key":"10.1016\/S0190-9622(96)90122-X_BIB85","first-page":"131","article-title":"Thalidomide therapy: an open trial","volume":"24","author":"Naafs","year":"1985","journal-title":"Int J Dermatol"},{"key":"10.1016\/S0190-9622(96)90122-X_BIB86","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0306-9877(89)90094-7","article-title":"Thalidomide: A therapy for the immunological consequences of HIV infection?","volume":"30","author":"Gunzler","year":"1989","journal-title":"Med Hypotheses"},{"key":"10.1016\/S0190-9622(96)90122-X_BIB87","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/tera.1420380307","article-title":"Proposed mechanisms of action in thalidomide embryopathy","volume":"38","author":"Stephens","year":"1988","journal-title":"Teratology"},{"key":"10.1016\/S0190-9622(96)90122-X_BIB88","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1097\/00005072-199011000-00003","article-title":"A quantitative ultrastructural study of motor and sensory lumbosacral nerve roots in the thalidomide-treated rabbit fetus","volume":"49","author":"De Iongh","year":"1990","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/S0190-9622(96)90122-X_BIB89","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1136\/jnnp.31.6.543","article-title":"Thalidomide neuropathy: a clinical, electrophysiological, and histological follow-up study","volume":"31","author":"Fullerton","year":"1968","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/S0190-9622(96)90122-X_BIB90","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1001\/archderm.1984.01650390060012","article-title":"Thalidomide neurotoxicity","volume":"120","author":"Clemmensen","year":"1984","journal-title":"Arch Dermatol"},{"key":"10.1016\/S0190-9622(96)90122-X_BIB91","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1365-2133.1985.tb02323.x","article-title":"Development of polyneuropathy during thalidomide therapy","volume":"112","author":"Wulff","year":"1985","journal-title":"Br J Dermatol"},{"key":"10.1016\/S0190-9622(96)90122-X_BIB92","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1001\/archderm.1994.01690010070009","article-title":"Thalidomide neuropathy incidence and clinicoelectrophysiologic findings in 42 patients","volume":"130","author":"Ochonisky","year":"1994","journal-title":"Arch Dermatol"},{"key":"10.1016\/S0190-9622(96)90122-X_BIB93","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/mus.880090907","article-title":"Thalidomide neuropathy: an electrophysiologic study","volume":"9","author":"Lagueny","year":"1986","journal-title":"Muscle Nerve"},{"key":"10.1016\/S0190-9622(96)90122-X_BIB94","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1177\/095646249100200514","article-title":"Thalidomide, peripheral neuropathy and AIDS","volume":"2","author":"Fuller","year":"1991","journal-title":"Int J STD AIDS"},{"key":"10.1016\/S0190-9622(96)90122-X_BIB95","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1001\/archderm.1984.01650470072016","article-title":"Thalidomide-induced peripheral neuropathy","volume":"120","author":"Aronson","year":"1984","journal-title":"Arch Dermatol"},{"key":"10.1016\/S0190-9622(96)90122-X_BIB96","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/BF00313852","article-title":"Thalidomide-induced peripheral neuropathy: a prospective clinical, neurophysiological and pharmacogenetic evaluation","volume":"233","author":"Hess","year":"1986","journal-title":"J Neurol"},{"key":"10.1016\/S0190-9622(96)90122-X_BIB97","first-page":"39","article-title":"The mechanism of the push and pull principle VIII: endocrine effects of thalidomide and its analogues","volume":"194","author":"Locker","year":"1971","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"10.1016\/S0190-9622(96)90122-X_BIB98","first-page":"313","article-title":"Actualite du thalidomide","volume":"117","author":"Revuz","year":"1990","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/S0190-9622(96)90122-X_BIB99","first-page":"625","article-title":"Thalidomide and exfoliative dermatitis","volume":"56","author":"Salafia","year":"1988","journal-title":"Int J Lepr"},{"key":"10.1016\/S0190-9622(96)90122-X_BIB100","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1159\/000246827","article-title":"Erythroderma due to thalidomide: report of two cases","volume":"189","author":"Bielsa","year":"1994","journal-title":"Dermatology"},{"key":"10.1016\/S0190-9622(96)90122-X_BIB101","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/0140-6736(91)91221-F","article-title":"Thalidomide hypersensitivity in AIDS","volume":"337","author":"Williams","year":"1991","journal-title":"Lancet"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019096229690122X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019096229690122X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T21:32:28Z","timestamp":1759267948000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S019096229690122X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,12]]},"references-count":101,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1996,12]]}},"alternative-id":["S019096229690122X"],"URL":"https:\/\/doi.org\/10.1016\/s0190-9622(96)90122-x","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[1996,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rediscovering thalidomide: A review of its mechanism of action, side effects, and potential uses","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S0190-9622(96)90122-X","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1996 Published by Mosby, Inc.","name":"copyright","label":"Copyright"}]}}